Gold prices just lower; monthly gains on track
Investing.com - Jefferies lowered its price target on Revvity Inc (NYSE:RVTY) to $100.00 from $106.00 on Monday, while maintaining a Hold rating on the stock. According to InvestingPro data, the company currently trades at a P/E ratio of 39.45 and shows a perfect Piotroski Score of 9, indicating strong financial health.
The price target reduction follows Revvity’s guidance adjustment related to China’s drug-related group (DRG) policies, which Jefferies notes will impact the company’s financial outlook despite previous assurances about value-based procurement (VBP) concerns.
According to Jefferies, these China headwinds are expected to reduce Revvity’s organic revenue and earnings per share by approximately 1% each, raising questions about the sustainability of the company’s software business trends.
The research firm also expressed concerns about Revvity’s mid-term operating profit margin outlook, noting expectations that the company will enter 2026 with margins around 28%.
Jefferies questioned why Revvity’s cost-cutting measures have been unable to offset these headwinds in the current year, comparing the situation to competitor Danaher (NYSE:DHR)’s more effective cost management approach.
In other recent news, Revvity Inc. reported its second-quarter 2025 earnings, outperforming analyst expectations. The company posted an adjusted earnings per share (EPS) of $1.18, surpassing the forecasted $1.14. Additionally, Revvity’s revenue reached $720 million, exceeding the anticipated $710.39 million. These results highlight the company’s strong financial performance for the quarter. Despite the positive earnings and revenue results, the stock experienced a premarket decline. This development is part of recent updates concerning the company. Investors may find these financial results noteworthy as they reflect Revvity’s ability to exceed market expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.